RV Functional Abnormalities in Arrhythmogenic Cardiomyopathy

Quick Takes

  • Echocardiographic markers of subtle RV dysfunction include RV deformation pattern recognition and RV mechanical dispersion.
  • These two parameters were validated in two cohorts of patients or mutation-positive family members with arrhythmogenic cardiomyopathy.
  • The parameters were found to be independently associated with ventricular arrhythmias, with an even stronger association when combined.
  • Deformation imaging can be used to risk stratify early in disease by detecting early structural and functional abnormalities that suggest increased risk of ventricular arrhythmias.

Study Questions:

Beyond the conventional imaging parameters which are incorporated into the diagnostic criteria of arrhythmogenic cardiomyopathy (AC), two echocardiographic measurements (right ventricular [RV] deformation patterns and RV mechanical dispersion) have been separately validated in the centers in which they were developed as predictors of ventricular arrhythmias (VA). Are these measurements associated with VA in a large cohort recruited from two different centers, and does combining the two parameters add value in risk stratifying AC?

Methods:

This was a retrospective study using independent AC cohorts from two large academic medical centers (Utrecht, The Netherlands and Oslo, Norway), which were age- and sex-matched to each other. Each cohort consisted of AC probands and mutation-positive family members who had available speckle-tracking echocardiographic examination with high enough image quality to enable both RV (sub-tricuspid) deformation and mechanical dispersion analyses. The cohorts were initially kept separate and used to externally validate the measurement derived at the opposite site (i.e., the association of RV deformation and VA was evaluated in the Oslo cohort and compared to the Utrecht cohort where it was initially developed, and vice versa). Finally, the cohorts were merged and used to assess the predictive value of the combination. All measurements were performed by a single observer who was newly trained in both RV deformation imaging techniques and blinded to clinical outcomes. Interobserver and intraobserver variability were assessed by reanalyzing selected studies from each database. Outcomes included life-threatening arrhythmias (defined as a documented history of sustained ventricular tachycardia, aborted cardiac arrest, or appropriate implantable cardioverter-defibrillator therapy) and were adjudicated retrospectively from the time of the index echocardiogram. Disease stage was also retrospectively assessed using the 2010 revised Task Force Criteria (TFC) for AC.

Results:

There were 160 subjects, 80 from each center (55% women, age 41 ± 17 years), made up of 68 probands and 92 mutation-positive family members. Plakophilin-2 was the most common pathogenic mutation in both cohorts (90% in Oslo and 89% in Utrecht). Most probands (81%) and about half of the family members (46%) fulfilled a definite diagnosis of AC as defined by the 2010 TFC. Life-threatening VA had occurred in 29% of subjects, with similar rates in both Oslo and Utrecht cohorts (31% vs. 28%, respectively).

Among VA patients, 98% had abnormal RV deformation type II (34%) or type III (64%). The odds of VA increased with each step-up in type, even when adjusted for age (odds ratio [OR], 3.55; 95% confidence interval [CI], 1.97-6.42; p < 0.001). RV mechanical dispersion showed similar association with risk of VA, with every 10 ms-increase in dispersion increasing the odds of VA by 45% (OR, 1.45; 95% CI, 1.23-1.71; p < 0.001). The optimal cutoff for RV mechanical dispersion to detect patients with a history of VA was 24 ms.

Combining the measurements had some additive value. The AUC of the receiver operator curve increased from 0.74 (95% CI, 0.66-0.82) for just RV deformation to 0.80 (95% CI, 0.73-0.87); p = 0.001 when two measurements were combined, an association similar to that between cardiac magnetic resonance (CMR) imaging and VA.

Conclusions:

This study externally validated the use of both RV deformation pattern recognition and RV mechanical dispersion in patients with AC or mutation-positive family members. RV deformation patterns and mechanical dispersion were independently associated with life-threatening VA. There was a significant improvement in this association when RV deformation patterns and mechanical dispersion were combined, with an AUC of 0.80, which is similar to the association between CMR imaging and VA.

Perspective:

This impressive study of two large cohorts is the first to look at RV deformation patterns and RV mechanical dispersion in both patients with AC and their mutation-positive family members. Current risk stratification tools have not included regional and subtle RV function on echocardiography, but instead relied on the global RV function and RV ejection by CMR. This study found that both abnormal deformation patterns and prolonged RV mechanical dispersion were independently associated with VA in these patients. Notably, the additive value of the two parameters increased the association with VA even more. The association between RV deformation patterns and mechanical dispersion and VA was equal to the association between CMR imaging and VA. However, there are many practical advantages to echocardiography over CMR, including cost and relative ease with which studies can be obtained and repeated over time. With the rapid expanse of cascade genetic testing, there will be a significant increase in mutation detection, often in asymptomatic genotype-positive family members who still have an important risk of ventricular arrhythmia. Use of this relatively straightforward echocardiographic deformation imaging may very well prove to be of great use for risk stratification in early disease, given its high sensitivity for ruling out life-threatening arrhythmias. Study limitations included its cross-sectional design with retrospective outcome adjudication, and to truly assess a predictive value, a prospective trial needs to be done. Simultaneously, a prospective trial would have to establish the frequency with which screening should be done.

Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Implantable Devices, Genetic Arrhythmic Conditions, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Echocardiography/Ultrasound, Magnetic Resonance Imaging

Keywords: Arrhythmias, Cardiac, Arrhythmogenic Right Ventricular Dysplasia, Cardiomyopathies, Defibrillators, Implantable, Diagnostic Imaging, Echocardiography, Genotype, Heart Arrest, Heart Failure, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Mutation, Risk Assessment, Tachycardia, Ventricular, Ventricular Function, Right


< Back to Listings